[在损伤中激活Peroxisome增殖器受体-α:机制和治疗影响]
1Department of Wound Infection and Special Drugs Research, Daping Hospital, Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing 400042, China. Corresponding author: Ao Shengxiang,
Zhonghua wei zhong bing ji jiu yi xue
|September 29, 2025
概括
过氧体增殖器激活受体-α (PPAR-α) 调节关键的生理过程,并与损伤有关. 针对PPAR-α提供了开发新脏保护策略的潜力.
科学领域:
- 分子生物学分子生物学
- 脏生理学 脏生理学
- 代谢性疾病研究研究.
背景情况:
- 过氧体增殖器激活受体-α (PPAR-α) 对于能量恒温,氧化还原平衡,炎症和铁亡至关重要.
- 功能障碍导致由于代谢和分泌功能受损导致系统性并发症.
- 损伤的原因多种多样,包括急性因素 (缺血/反,毒素,败血症) 和慢性疾病 (糖尿病病,高血压病).
研究的目的:
- 审查PPAR-α的结构,功能和调控机制.
- 在各种损伤模型中阐明PPAR-α的分子调节网络.
- 评估PPAR-α作为脏保护的治疗点.
主要方法:
- 对PPAR-α结构,功能和调节的文献综述.
- 对PPAR-α在急性损伤 (AKI) 和慢性病 (CKD) 发病过程中的作用的系统分析.
- 与损伤相关的PPAR-α在代谢,抗氧化,抗炎症,抗纤维化和抗铁化机制的概述.
主要成果:
- PPAR-α在调节受损伤影响的生理过程中发挥着核心作用.
- PPAR-α影响了参与AKI和CKD病变的多个途径.
- PPAR-α表现出与脏保护相关的抗炎,抗氧化,抗纤维和抗ferroptotic作用.
结论:
- PPAR-α是理解和治疗损伤的重要分子标.
- 针对PPAR-α的向干预对开发新的脏保护策略具有前景.
- 对PPAR-α机制的进一步研究可以为病的临床应用提供理论基础.
相关概念视频
01:29Acute Kidney Injury II: Pathophysiology
899
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
899
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
260
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
260
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
936
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
936
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:22Acute Kidney Injury I: Introduction
577
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
577
01:20Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297